Biología y Biomedicina >
Centro Andaluz de Biología del Desarrollo (CABD) >
(CABD) Artículos >
Closed Access item The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression
|Authors:||Pittman, Alan M.|
Lips, Esther H.
Van Wezel, Tom
Gómez-Skarmeta, José Luis
Houlston, Richard S.
|Keywords:||Colorectal cancer (CRC), 18q21 variation, SMAD7 expression, TGF-beta signaling|
|Publisher:||Cold Spring Harbor Laboratory Press|
|Citation:||Genome Research 19(6): 987-993 (2009)|
|Abstract:||Recent genome-wide scans for colorectal cancer (CRC) have revealed the SMAD7 (mothers against decapentaplegic homolog 7) gene as a locus associated with a modest, but highly significant increase in CRC risk. To identify the causal basis of the association between 18q21 variation and CRC, we resequenced the 17-kb region of linkage disequilibrium and evaluated all variants in 2532 CRC cases and 2607 controls. A novel C to G single nucleotide polymorphism (SNP) at 44,703,563 bp was maximally associated with CRC risk (P = 5.98 × 10−7; ≥1.5-fold more likely to be causal than other variants). Using transgenic assays in Xenopus laevis as a functional model, we demonstrate that the G risk allele leads to reduced reporter gene expression in the colorectum (P = 5.4 × 10−3). Electrophoretic mobility shift assays provided evidence for the role of Novel 1 in transcription factor binding. We propose that the novel SNP we have identified is the functional change leading to CRC predisposition through differential SMAD7 expression and, hence, aberrant TGF-beta signaling.|
|Description:||7 páginas, 4 figuras, 1 tabla.|
|Publisher version (URL):||http://dx.doi.org/10.1101/gr.092668.109|
|Appears in Collections:||(CABD) Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.